Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: LUTERA — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for LUTERA (levonorgestrel and ethinyl estradiol) filed by Mayne Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUTERA (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for LUTERA (LEVONORGESTREL AND ETHINYL ESTRADIOL)